Health Apr 02 Diabetes advocates hold out hope as a bipartisan bill revives efforts to lower insulin costs By Ali Swenson, Associated Press
Politics Jan 16 Watch 8:25 New law caps insulin prices for some with diabetes, but cost remains high for others Diabetics will now see a break in their out-of-pocket costs for insulin. Sanofi, one of the leading manufacturers of the hormone, joined two other major pharmaceutical companies in capping their insulin copays at $35. This comes after years of pressure… By Laura Barrón-López, Shrai Popat
Health Mar 05 Analysis: Eli Lilly is capping insulin copays at $35. Here are 5 questions answered Two scholars who have researched insulin pricing explain why Eli Lilly is dramatically cutting the cost of some of its insulin products and how it may improve access to this essential medical treatment. By Dana Goldman, Karen Van Nuys, The Conversation
Health Mar 01 Watch 5:12 Pharmaceutical giant slashes insulin prices after pressure from government and consumers More than seven million Americans rely on insulin and prices for the life-saving drug have sky-rocketed. With pressure mounting on pharmaceutical companies to address the cost of diabetes care, Eli Lilly announced it’s cutting prices for its most popular insulin… By Geoff Bennett, Courtney Norris